Form 4: Merck Director Acquires Phantom Stock Units

Christine E. Seidman, a director at Merck & Co., Inc., acquired phantom stock units on June 28, 2024, according to a Form 4 filing with the SEC.

Summary

• On June 28, 2024, Christine E. Seidman, a director at Merck & Co., Inc., acquired phantom stock units.
• The transaction involved the acquisition of 65.63 phantom stock units at a price of $123.8.
• Following the transaction, Ms. Seidman beneficially owns 14,815.5246 derivative securities.
• The phantom stock units are to be settled 100% in cash upon the reporting person's termination of service, according to a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
• Ms. Seidman also directly owns 100 shares of Merck common stock.

Sentiment

Score: 5

Explanation: This is a routine transaction disclosure, so the sentiment is neutral. It reflects standard compensation practices for directors.

Future Outlook

The phantom stock units will be settled in cash upon the director's termination of service, according to a pre-determined distribution schedule.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders of a company, such as directors and officers, trade the company's securities. This filing indicates a change in Ms. Seidman's beneficial ownership of Merck securities.

Key Dates